Pfizer 2017 Annual Review: The Power of Science

Primary tabs

Pfizer 2017 Annual Review: The Power of Science

Pfizer’s 2017 integrated annual review provides an in-depth look at the company’s financial, social and environmental performance throughout 2017.

This year’s online report highlights how The Power of Science drives every aspect of Pfizer’s business, from patient access and philanthropy, to research and development, to manufacturing.

View the full report at www.Pfizer.com/annual and check this page for highlights from the 2017 annual review.

Content from this campaign

Using the Science of Partnerships to Drive Patient Impact
In Africa, patients can outnumber doctors 3,000 to 1. That’s one of the reasons why Pfizer is dedicated to fostering innovative partnerships that allow us to mobilize resources to help find new and unique solutions that increase access to needed health care. Our colleague Willy Soriney, Strategic Partnership Director, works in Kenya using the science of partnerships to look for new...
Jun 19, 2018 10:00 AM ET
Tackling Antimicrobial Resistance with The Power of Science
Antimicrobial resistance (AMR), or the ability of a bacterium, virus, or fungus to develop resistance to the medicines commonly used to treat them, is one of the leading global public health threats today. Currently, AMR causes more than 700,000 deaths annually. If left unchecked, this number is expected to rise to 10 million deaths annually by 2050. In collaboration with the infectious...
May 31, 2018 10:00 AM ET
Advancing The Power of Science Behind Immuno-Oncology
Pfizer’s advances in oncology demonstrate the Power of Scientific innovation to help improve lives, particularly the power of Immuno-oncology (I-O). Immuno-oncology uses the natural ability of the body’s immune system to recognize and fight tumors. This past year, Pfizer continued to advance its work in I-O because we recognize the urgency of finding anti-cancer alternatives to help patients...
May 8, 2018 12:30 PM ET
Giving Millions a Shot
We are proud to work with Gavi, the Vaccine Alliance and the United Nations' (UN) Shot@Life campaign to ensure Pfizer’s life-saving vaccines reach those who need them most. As a part of our partnership with Gavi, we have committed to supply up to 740 million doses of a critical vaccine at its lowest global price through 2025. To date, we have provided 300 million doses of the vaccine,...
Apr 25, 2018 10:45 AM ET
Using the Power of Partnerships to Support Global Goal 5: Gender Equality
At Pfizer, we are proud to support the United Nations Sustainable Development Goals (SDGs), specifically Goal 5: Gender Equality. Equality across genders is fundamental to advancing all 17 of the SDGs, which in turn is connected to advancing global health. This year and every year, Pfizer harnesses the power of partnerships with various organizations to help empower and mobilize women...
Apr 10, 2018 10:00 AM ET

Pages